Sarah Wootton

Associate Professor

University of Guelph

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sarah Wootton is an Associate Professor at the University of Guelph, Canada. Her research focuses on immunology, gene delivery systems, and vaccine development, as evidenced by her recent publications on therapeutic antibodies, AAV vectors, and mucosal vaccination strategies. Her work aims to enhance understanding of immune responses and develop innovative approaches to combat infectious diseases and cancer.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

CANADA

View details

Byram Bridle

Associate Professor

University of Guelph

CANADA

View details

James Strong

University of Manitoba

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Wootton

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies

Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques

Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model

Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation

AAV Vectors Pseudotyped with Capsids from Porcine and Bovine Species Mediate In Vitro and In Vivo Gene Delivery

Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene

Overcoming Barriers to Preventing and Treating <i>P. aeruginosa</i> Infections Using AAV Vectored Immunoprophylaxis

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma

Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures

Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin

Macrophage Depletion via Clodronate Pretreatment Reduces Transgene Expression from AAV Vectors In Vivo

Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils

Collaborators (7)

Geoffrey Wood

Logan Banadyga

Anthony Mutsaers

Amine Kamen

Cezar M. Khursigara

Byram Bridle

James Strong

Make your next move.